Mesoblast Seeks Orphan Drug Status for Rexlemestrocel-L in Treating Severe Congenital Heart Disease

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that it has filed for orphan ...

November 27, 2023 | Monday | News
Surge in Respiratory Illness Overwhelms Chinese Hospitals, WHO Requests Data

A wave of respiratory illnesses, accompanied by alarming clusters of pneumonia cases, has inundated hospitals in northern China, sparking deep concerns abo...

November 25, 2023 | Saturday | News
STADA strikes partnership with CR Sanjiu in China to drive growth of its cough and cold portfolio

Partnership agreement signed on 22 November to broaden distribution and promotion of cough and cold brands such as Shidagong, Gelite and Ruike in China&n...

November 24, 2023 | Friday | News
Merck Acquires Caraway Therapeutics as Dementia Discovery Fund Facilitates Groundbreaking Move

The Dementia Discovery Fund (DDF), a SV Health Investors (SV) fund specialized in pursuing transformational therapeutic approaches for dementias including ...

November 23, 2023 | Thursday | News
Wipro and NVIDIA Collaborate to Integrate Generative AI into Healthcare Insurance

Wipro Limited  a leading technology services and consulting company, today announced a collaboration with NVIDIA to help healthcare companies accelera...

November 22, 2023 | Wednesday | News
Mass General Brigham's Genetic Disease Center Launches Global Genomic Medicine Training in UAE

Genomic medicine, also known as precision medicine, offers transformative opportunities to reshape health care and public health from a 'one size fits all'...

November 21, 2023 | Tuesday | News
ABC Medical Introduces Groundbreaking Behavioral Health Treatment Program

ABC Medical, a behavioral healthcare start-up, headquartered in Reading, Massachusetts, wants to offer an alternative – a comprehensive treatment pro...

November 20, 2023 | Monday | News
DiagnaMed Expedites CERVAI™ Brain Health AI Platform Commercialization Through SOPHIE Program Acceptance.

The SOPHIE program supports collaborative projects for Ontario-based life science firms in the later stages of commercialization. DiagnaMed can leverage fu...

November 16, 2023 | Thursday | News
SciSparc Celebrates Major Breakthrough with Positive Results Demonstrating Remarkable Impact on Alzheimer's Agitation in Treatment

SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central...

November 16, 2023 | Thursday | News
Paragon 28 Launches BEAST™ Cortical Fibers Expanding its Biologics Portfolio

These loose cortical fibers are engineered to complement specific surgical applications in the foot and ankle and are flexible upon hydration allowing for ...

November 15, 2023 | Wednesday | News
Intelligent Scopes, a Claritas HealthTech Subsidiary, Takes Charge of Global Deployment for CystoSmart™ AI Diagnostic Software in Bladder Cancer Detection

Claritas, a leader in image enhancement and AI diagnostic solutions has developed pioneering technology for real-time precision detection of conditions in ...

November 13, 2023 | Monday | News
FDA Approves First Vaccine to Prevent Disease Caused by Chikungunya Virus

The chikungunya virus is primarily transmitted to people through the bite of an infected mosquito. Chikungunya is an emerging global health threat with at ...

November 10, 2023 | Friday | News
Bio-Botanica®'s Puresterol® Serums Show Wrinkle Reduction in Clinical Trials

Pueraria mirifica grows only in the rich soils of the high-altitude rainforests of Thailand and has been used by the Thais for a millennium as a rejuvenato...

November 10, 2023 | Friday | News
Cancer Drug Parity Act Gains Strong Support from Leading Healthcare Organizations

The International Myeloma Foundation (IMF), which leads the Coalition to Improve Access to Cancer Care (CIACC), fervently supports the Cancer Drug Parity A...

November 09, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close